Walgreen Boots Alliance

WBA-Q

NASDAQ:WBA

47.45
0.38 (0.81%)
Walgreens Boots Alliance, Inc. is an American holding company headquartered in Deerfield, Illinois that owns Walgreens, Boots, and a number of pharmaceutical manufacturing, wholesale and distribution companies.
More at Wikipedia
WBA Fundamental Data  by TradingView
WBA Chart  by TradingView
Technical Analysis for WBA  by TradingView

Analysis and Opinions about WBA-Q

Signal
Opinion
Expert
DON'T BUY
DON'T BUY
Walgreen Boots Alliance (WBA-Q)
September 12, 2019

Attractive valuation. Owns CVS Health instead, which is vertically integrated. So CVS is better positioned in the new world of health in the US to bring down costs. CVS trading at 9-10x earnings.

Show full opinionHide full opinion
Walgreen Boots Alliance (WBA-Q)
September 12, 2019

Attractive valuation. Owns CVS Health instead, which is vertically integrated. So CVS is better positioned in the new world of health in the US to bring down costs. CVS trading at 9-10x earnings.

specialty stores
0 Comments
Christine Poole

☆ Unlock Ratings

Price
$55.560
Owned
No
HOLD
HOLD
Walgreen Boots Alliance (WBA-Q)
September 9, 2019
Bad news is already factored in. Bringing health care into the mix will give them more sustainable earnings, downturn resistant earnings, and maintain the multiple. Don't rush to sell this.
Show full opinionHide full opinion
Walgreen Boots Alliance (WBA-Q)
September 9, 2019
Bad news is already factored in. Bringing health care into the mix will give them more sustainable earnings, downturn resistant earnings, and maintain the multiple. Don't rush to sell this.
specialty stores
0 Comments
John Zechner

☆ Unlock Ratings

Price
$55.590
Owned
Unknown
COMMENT
COMMENT
Walgreen Boots Alliance (WBA-Q)
August 27, 2019

Some of the big pharma concerns are real as President Trump is against drug pricing. Ultimately he does not think it will be devastating. He likes the industry, but prefers others like Walgreens.

Show full opinionHide full opinion
Walgreen Boots Alliance (WBA-Q)
August 27, 2019

Some of the big pharma concerns are real as President Trump is against drug pricing. Ultimately he does not think it will be devastating. He likes the industry, but prefers others like Walgreens.

specialty stores
0 Comments
Don Lato

☆ Unlock Ratings

Price
$49.450
Owned
Unknown
HOLD
HOLD
Walgreen Boots Alliance (WBA-Q)
July 29, 2019

He likes this company. His model price is over $84. They have been hit by the news that Amazon was going into their space, but he questions how that might happen. He would buy even more at $43.

Show full opinionHide full opinion
Walgreen Boots Alliance (WBA-Q)
July 29, 2019

He likes this company. His model price is over $84. They have been hit by the news that Amazon was going into their space, but he questions how that might happen. He would buy even more at $43.

specialty stores
0 Comments
Brian Acker, CA

☆ Unlock Ratings

Price
$55.130
Owned
Yes
COMMENT
COMMENT
Walgreen Boots Alliance (WBA-Q)
July 3, 2019

I gained $1 from a recent call and put, but WGA is volatile. Take the gains or wait till the October call? Amazon is having trouble disrupting WBA's healthcare business and sector. If you want to take gains, then take half the position you got and close it out--take your profits and let the rest of your money ride.

Show full opinionHide full opinion
Walgreen Boots Alliance (WBA-Q)
July 3, 2019

I gained $1 from a recent call and put, but WGA is volatile. Take the gains or wait till the October call? Amazon is having trouble disrupting WBA's healthcare business and sector. If you want to take gains, then take half the position you got and close it out--take your profits and let the rest of your money ride.

specialty stores
0 Comments
Richard Croft

☆ Unlock Ratings

Price
$55.190
Owned
Unknown
DON'T BUY
DON'T BUY
Walgreen Boots Alliance (WBA-Q)
June 18, 2019
The market in general has gone up and this have been moving down. He would need to see a move above $60 before he gets interested. He would look elsewhere.
Show full opinionHide full opinion
Walgreen Boots Alliance (WBA-Q)
June 18, 2019
The market in general has gone up and this have been moving down. He would need to see a move above $60 before he gets interested. He would look elsewhere.
specialty stores
0 Comments
Javed Mirza

☆ Unlock Ratings

Price
$52.800
Owned
No
DON'T BUY
DON'T BUY
Walgreen Boots Alliance (WBA-Q)
June 17, 2019
Is it real estate reflected in its current price? The pharmacy retail space has come off a lot due to disruption. In this space, he bought Walmart instead; they do everything better yet cheaper. Disruption will make it harder for WBA to compete. The real estate is not valued in, but nothing tells him that it should either. Pharmacy retail is another industry under scrutiny, and he feels Walmart will prevail.
Show full opinionHide full opinion
Walgreen Boots Alliance (WBA-Q)
June 17, 2019
Is it real estate reflected in its current price? The pharmacy retail space has come off a lot due to disruption. In this space, he bought Walmart instead; they do everything better yet cheaper. Disruption will make it harder for WBA to compete. The real estate is not valued in, but nothing tells him that it should either. Pharmacy retail is another industry under scrutiny, and he feels Walmart will prevail.
specialty stores
0 Comments
Andrew Pink

☆ Unlock Ratings

Price
$52.810
Owned
No
BUY
BUY
Walgreen Boots Alliance (WBA-Q)
June 14, 2019

$79.57 is his model price, 50% higher than the current price. Dirt cheap now. He has recommended this in the past. The Amazon fear is overdone. Be patient with this value name.

Show full opinionHide full opinion
Walgreen Boots Alliance (WBA-Q)
June 14, 2019

$79.57 is his model price, 50% higher than the current price. Dirt cheap now. He has recommended this in the past. The Amazon fear is overdone. Be patient with this value name.

specialty stores
0 Comments
Brian Acker, CA

☆ Unlock Ratings

Price
$52.570
Owned
Yes
N/A
N/A
Walgreen Boots Alliance (WBA-Q)
May 30, 2019
He was not happy with their last earnings report. There was a weakening on margins on their generic drug business and they are being affected with BREXIT because of their affiliation with Boots. He owns CVS-N who have a more vibrant long term plan. WBA-Q does not have a catalyst.
Show full opinionHide full opinion
Walgreen Boots Alliance (WBA-Q)
May 30, 2019
He was not happy with their last earnings report. There was a weakening on margins on their generic drug business and they are being affected with BREXIT because of their affiliation with Boots. He owns CVS-N who have a more vibrant long term plan. WBA-Q does not have a catalyst.
specialty stores
0 Comments
Gordon Reid

☆ Unlock Ratings

Price
$50.550
Owned
No
HOLD
HOLD
Walgreen Boots Alliance (WBA-Q)
May 29, 2019
He sill owns WBA-Q. Both have been under tremendous pressure. He feels the entry of Amazon in to mail order prescriptions has hurt along with a move towards generic pricing on drugs. He feels it is way over done. These companies are foundations within the US. At some point they will bottom out, but he is not ready to add to his holdings at this point.
Show full opinionHide full opinion
Walgreen Boots Alliance (WBA-Q)
May 29, 2019
He sill owns WBA-Q. Both have been under tremendous pressure. He feels the entry of Amazon in to mail order prescriptions has hurt along with a move towards generic pricing on drugs. He feels it is way over done. These companies are foundations within the US. At some point they will bottom out, but he is not ready to add to his holdings at this point.
specialty stores
0 Comments
Don Lato

☆ Unlock Ratings

Price
$51.130
Owned
Unknown
BUY
BUY
Walgreen Boots Alliance (WBA-Q)
May 23, 2019
It is global. It will have headline noise because of the election. It could bounce back but is under pressure from dispensing fees. There are other ways to get dividend growth. 75% of their business is retail.
Show full opinionHide full opinion
Walgreen Boots Alliance (WBA-Q)
May 23, 2019
It is global. It will have headline noise because of the election. It could bounce back but is under pressure from dispensing fees. There are other ways to get dividend growth. 75% of their business is retail.
specialty stores
0 Comments
Robert Lauzon

☆ Unlock Ratings

Price
$51.610
Owned
Unknown
BUY
BUY
Walgreen Boots Alliance (WBA-Q)
April 22, 2019
vs. Walgreen Still cheap. $82.60 is his target price. Some stocks you go to war with when the market or sector is negative, when investors beat up a stock. You can be contrarian and do very well with this.
Show full opinionHide full opinion
Walgreen Boots Alliance (WBA-Q)
April 22, 2019
vs. Walgreen Still cheap. $82.60 is his target price. Some stocks you go to war with when the market or sector is negative, when investors beat up a stock. You can be contrarian and do very well with this.
specialty stores
0 Comments
Brian Acker, CA

☆ Unlock Ratings

Price
$54.100
Owned
Unknown
PAST TOP PICK
PAST TOP PICK
Walgreen Boots Alliance (WBA-Q)
April 22, 2019
(A Top Pick Apr 25/18, Down 16%) He sold upon news that its generic drug margins were deteriorating. You must look at your stocks with fresh eyes when news arises. Have an unemotional sell discipline.
Show full opinionHide full opinion
Walgreen Boots Alliance (WBA-Q)
April 22, 2019
(A Top Pick Apr 25/18, Down 16%) He sold upon news that its generic drug margins were deteriorating. You must look at your stocks with fresh eyes when news arises. Have an unemotional sell discipline.
specialty stores
0 Comments
Gordon Reid

☆ Unlock Ratings

Price
$54.100
Owned
No
PARTIAL BUY
PARTIAL BUY
Walgreen Boots Alliance (WBA-Q)
April 11, 2019
The PE is lower than historically. He historically owned CVS-N. The problem with WBA-N is the political noise around drug pricing and these companies are just middlemen. He sold CVS-N a while ago. There is a lot of risk in the names for the next 5 years. Buy a half position in the name and buy the rest on later on weakness.
Show full opinionHide full opinion
Walgreen Boots Alliance (WBA-Q)
April 11, 2019
The PE is lower than historically. He historically owned CVS-N. The problem with WBA-N is the political noise around drug pricing and these companies are just middlemen. He sold CVS-N a while ago. There is a lot of risk in the names for the next 5 years. Buy a half position in the name and buy the rest on later on weakness.
specialty stores
0 Comments
Bryden Teich

☆ Unlock Ratings

Price
$54.713
Owned
No
TOP PICK
TOP PICK
Walgreen Boots Alliance (WBA-Q)
March 13, 2019
It's suffered the double-whammy of eliminating drug pricing talk by politicians in the U.S. and fears of Amazon getting into the pharma space. WBA has increased its dividend 43 years in a row and expect one in June. Trades at lower than 10x earnings. He thinks pricing fears are overblown. Targets this in the mid-$70s within 12 months. (Analysts’ price target is $74.35)
Show full opinionHide full opinion
Walgreen Boots Alliance (WBA-Q)
March 13, 2019
It's suffered the double-whammy of eliminating drug pricing talk by politicians in the U.S. and fears of Amazon getting into the pharma space. WBA has increased its dividend 43 years in a row and expect one in June. Trades at lower than 10x earnings. He thinks pricing fears are overblown. Targets this in the mid-$70s within 12 months. (Analysts’ price target is $74.35)
specialty stores
0 Comments
Don Lato

☆ Unlock Ratings

Price
$61.900
Owned
Yes
Showing 16 to 30 of 218 entries
Previous
Next Page
PixFuture exclusive partner.
© Stockchase Inc.